Premium Information is available for this item - Upgrade for $1 a day
6505-01-051-4809
Usp Cyclophosphamide For Injection
6505010514809 010514809 CYTOXAN 87-0502-01
November 2023
7
Marketplace 6505-01-051-4809
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-051-4809 5+ Documents (More...)
RQST NE Updated Every Day 6505-01-051-4809 RQST Updated Every Day 6505-01-051-4809 RQST NE Related Documents
6505-01-051-4809 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-051-4809
Usp Cyclophosphamide For Injection 010514809 6505-01-051-4809 5+ Documents ( More... ) https https
Cyclophosphamide For Injection 6505190009813 Cyclophosphamide For Injection 6505190009813 Data us 6505-01-051-4809
6505331907030 Cyclophosphamide For Injection 6505190009816 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-051-4809
Usp Cyclophosphamide For Injection 010514809 Cyclophosphamide For Injection 6505190009813 6505-
For Injection6505010514809 010514809 CYTOXAN For Injection6505011587889 011587889CYTOXAN For Injection6505010514809
010514809CYTOXAN 9816 010514809 https//www.nsnlookup.com https// https// CYTOXAN, LYOPOHILIZED NDC00015
For Injection6505011587889 011587889 CYTOXAN For Injection6505010514809 010514809CYTOXAN 9816 010514809
https//www.nsnlookup.com https// https// CYTOXAN https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01
Restrictions 6505-01-051-4809
6505-01-051-4809 is a Usp Cyclophosphamide For Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
End Users 6505-01-051-4809
- NASA (G57V)
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-051-4809
- Part Number
- Manufacturer
- Status
- 87-0502-01
- Manufacturer
- 29398 - Mead Johnson & Company, Llc (Active)
- Primary Buy
- Primary Buy
- CYTOXAN
- 29398 - Mead Johnson & Company, Llc (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-051-4809
- Characteristic
- Specifications
- Active Medicament Medicinal Strength [AKJA]
- Specifications
- 500.000 Milligrams Cyclophosphamide Active Ingredient And 225.000 Milligrams Sodium Chloride Active Ingredient
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 1.000 Each
- Special Features [FEAT]
- 30 Ml Vial Size
- Physical Form [AGXW]
- Powder
- Total Primary Container Quantity [CSCW]
- 12
NATO Stock Numbers Related to 6505-01-051-4809
Freight Information 6505-01-051-4809
6505-01-051-4809 has freight characteristics.. 6505-01-051-4809 has a variance between NMFC and UFC when transported by rail and the description should be consulted.